Document Detail


Pulmonary hemorrhage after percutaneous coronary intervention with abciximab therapy.
MedLine Citation:
PMID:  12479522     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Abciximab has a key role in the treatment of patients with acute coronary syndromes undergoing percutaneous coronary intervention; however, an increased risk of bleeding complications is well recognized. We report a case of serious pulmonary hemorrhage after use of abciximab therapy. A definitive indication and treatment guideline should be available to minimize serious bleeding complications. Additionally, respiratory symptoms should be monitored closely for early detection of serious pulmonary hemorrhage in patients receiving abciximab therapy during percutaneous coronary intervention.
Authors:
Rak Kyeong Choi; Nae Hee Lee; Dal Soo Lim; Suk keun Hong; Hweung Kon Hwang
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Mayo Clinic proceedings     Volume:  77     ISSN:  0025-6196     ISO Abbreviation:  Mayo Clin. Proc.     Publication Date:  2002 Dec 
Date Detail:
Created Date:  2002-12-13     Completed Date:  2003-01-02     Revised Date:  2013-12-13    
Medline Journal Info:
Nlm Unique ID:  0405543     Medline TA:  Mayo Clin Proc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1340-3     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Antibodies, Monoclonal / adverse effects*
Female
Hemorrhage / chemically induced*,  radiography
Humans
Immunoglobulin Fab Fragments / adverse effects*
Lung Diseases / chemically induced*,  radiography
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
Chemical
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Immunoglobulin Fab Fragments; 0/Platelet Glycoprotein GPIIb-IIIa Complex; X85G7936GV/abciximab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Management of persistent symptoms in patients with asthma.
Next Document:  Combined tracheal and esophageal stenting for palliation of tracheoesophageal symptoms from mediasti...